IBOK
ALNY icon

Independence Bank of Kentucky’s Alnylam Pharmaceuticals ALNY Stock Holding History

Independence Bank of Kentucky’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-50
Closed -$16.5K – 590
2026
Q1 		$16.5K Buy
50
+47
+1,567% +$16K ﹤0.01% 495
2025
Q4 		$1.19K Buy
+3
New +$1.33K ﹤0.01% 680
2023
Q3 		– Sell
-6
Closed -$1.14K – 483
2023
Q2 		$1.14K Buy
+6
New +$1.19K ﹤0.01% 501

Other funds holding ALNY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Independence Bank of Kentucky's ALNY Position: Q2 2026 in Review

Independence Bank of Kentucky sold out of Alnylam Pharmaceuticals (ALNY) in Q2 2026, closing a stake of 50 shares — an estimated $16.5K sold.

Independence Bank of Kentucky first reported a position in ALNY in Q2 2023 and held it in 3 quarters. The position peaked at $16.5K in Q1 2026. 358 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Independence Bank of Kentucky reported no remaining Alnylam Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Independence Bank of Kentucky sold 50 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $16.5K.
  • Independence Bank of Kentucky first reported a position in Alnylam Pharmaceuticals in Q2 2023 and held it in 3 quarters.
  • Independence Bank of Kentucky's Alnylam Pharmaceuticals position peaked at $16.5K in Q1 2026.
  • 358 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Independence Bank of Kentucky's 13F filing for Q2 2026, filed 13 Jul 2026.